Goldman Sachs
MDXG icon

Goldman Sachs’s MiMedx Group MDXG Stock Holding History

Goldman Sachs’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-305,000
Closed -$2.13M – 5853
2018
Q1 		$2.13M Buy
305,000
+298,300
+4,452% +$3.47M ﹤0.01% 3564
2017
Q4 		$84K Buy
6,700
+2,900
+76% +$35.4K ﹤0.01% 5802
2017
Q3 		$45K Sell
3,800
-41,800
-92% -$620K ﹤0.01% 6273
2017
Q2 		$683K Buy
45,600
+26,900
+144% +$359K ﹤0.01% 4813
2017
Q1 		$178K Buy
+18,700
New +$158K ﹤0.01% 5796
2016
Q3 		– Sell
-500
Closed -$4K – 7117
2016
Q2 		$4K Sell
500
-49,700
-99% -$387K ﹤0.01% 6943
2016
Q1 		$439K Sell
50,200
-9,800
-16% -$81.4K ﹤0.01% 4872
2015
Q4 		$562K Hold
60,000
– – ﹤0.01% 4823
2015
Q3 		$579K Sell
60,000
-3,900
-6% -$41.2K ﹤0.01% 4996
2015
Q2 		$741K Sell
63,900
-700
-1% -$7.2K ﹤0.01% 4820
2015
Q1 		$672K Buy
+64,600
New +$605K ﹤0.01% 4840
2014
Q4 		– Sell
-328,000
Closed -$2.34M – 7230
2014
Q3 		$2.34M Buy
328,000
+79,000
+32% +$551K ﹤0.01% 3785
2014
Q2 		$1.76M Buy
+249,000
New +$1.46M ﹤0.01% 4117

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs's MDXG Position: Q2 2026 in Review

Goldman Sachs increased its MiMedx Group (MDXG) stake by 125% in Q2 2026, buying an estimated $5.4M and bringing the position to 2,665,562 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3205.

Goldman Sachs first reported a position in MDXG in Q2 2013 and has held it in 45 quarters since. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Goldman Sachs held 2,665,562 shares of MiMedx Group worth $10.3M as of Q2 2026.
  • Goldman Sachs bought 1,480,001 MiMedx Group shares in Q2 2026, an estimated $5.4M.
  • MiMedx Group made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3205 holding.
  • Goldman Sachs first reported a position in MiMedx Group in Q2 2013 and has held it in 45 quarters since.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.